Journal of Radioanalytical Chemistry

, Volume 53, Issue 1–2, pp 291–298 | Cite as

The kinetics of incorporation of111In into m-tetraphenylporphine

  • A. D. Nunn
Medical Radionuclides and the Quality of Radiopharmaceuticals


An improved method is described for rapidly incorporating “carrier-free”111In into m-tetraphenylporphine to produce a lipid soluble complex of potential clinical usefulness. The reaction in glacial acetic acid is temperature dependent and markedly sensitive to the nature of the anion present. Halide ions completely inhibit incorporation of the111In. An unusual destruction of the porphyrin ring by nitrate in glacial acetic acid is reported.


Porphyrin Glacial Acetic Acid Macrocyclic Ligand Indium Atom Metalloporphyrin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. J. SEVEN, Metal Binding in Medicine, Lippincott, 1960, p. 95.Google Scholar
  2. 2.
    R. L. WILLSON, In: Iron Metabolism. CIBA Foundation Symp. 51, Elsevier, 1977, p. 331.Google Scholar
  3. 3.
    A. W. SEGAL, R. DETEIX, R. GARCIA, P. TOOTH, G. D. ZANELLI, A. C. AALLISON, J. Nucl. Med., 19 (1978) 1238.Google Scholar
  4. 4.
    H. J. DANPURE, P. OSMAN, I. P. HESSLEWOOD, J. Labelled Cpds and Radiopharmaceuticals, 16 (1979) 116.Google Scholar
  5. 5.
    F. R. LONGO, E. M. BROWN, D. J. QUIMBY, A. D. ADLER, M. MEOT-NER, Ann. N. Y. Acad. Sci., 206 (1973) 420.Google Scholar
  6. 6.
    J. WINKELMAN, S. RUBENFELD, J. G. McAFEE, J. Nucl. Med., 5 (1964) 462.Google Scholar
  7. 7.
    J. D. AUSTEN, S. McCONNELL, C. J. CARRANO, M. TSUTSUI, Canc. Treat. Rep., 62 (1978) 511.Google Scholar
  8. 8.
    M. BHATTI, W. BHATTI, E. MAST, Inorg. Nucl. Chem. Lett., 8 (1972) 133.CrossRefGoogle Scholar
  9. 9.
    M. V. MERRICK, A. D. NUNN, M. L. THAKUR, S. W. GUNASEKERA, Int. J. Nucl. Med. Biol., 2 (1975) 45.CrossRefGoogle Scholar
  10. 10.
    A. D. ADLER, F. R. LONG, F. KAMPAS., J. KIM, J. Inorg Nucl. Chem., 32 (1970) 2443.CrossRefGoogle Scholar
  11. 11.
    S. SUGATA, Y. MATSUSHIMA, Chem. Pharm. Bull., 26 (1978) 1071.Google Scholar
  12. 12.
    A. D. ADLER, F. R. LLONG J. D. FINARELLI, J. GOLDMACHER, J. ASSOUR, L. VORSAKOFF, J. Org. Chem., 32 (1967) 476.CrossRefGoogle Scholar
  13. 13.
    K. LETTS, R. A. MACKAY, Inorg. Chem., 14 (1975) 2990.CrossRefGoogle Scholar
  14. 14.
    J. CELEDA, D. G. TUCK, J. Inorg. Nucl Chem., 36 (1974) 373.CrossRefGoogle Scholar
  15. 15.
    P. PENKOSKE, E. J. POTCHEN, M. J. WELCH, T. J. WELCH, J. Nucl. Med., 10 (1969) 646.Google Scholar
  16. 16.
    M. J. WELCH, T.J. WELCH, In Radiopharmaceuticals G. Subramanian, (Ed.) Board of Nuclear Medicine 1975.Google Scholar

Copyright information

© Akadémiai Kiadó 1979

Authors and Affiliations

  • A. D. Nunn
    • 1
  1. 1.Division of Nuclear MedicineUpstate Medical CenterSyracuseUSA

Personalised recommendations